Association study of polymorphisms in the GluR5 kainate receptor gene (GRIK1) with schizophrenia

被引:32
作者
Shibata, H
Joo, A
Fujii, Y
Tani, A
Makino, C
Hirata, N
Kikuta, R
Ninomiya, H
Tashiro, N
Fukumaki, Y
机构
[1] Kyushu Univ, Med Inst Bioregulat, Div Dis Genes, Res Ctr Genet Informat, Fukuoka 812, Japan
[2] Fukuoka Prefectural Dazaifu Hosp Psychiat Ctr, Fukuoka, Japan
[3] Kyushu Univ, Grad Sch Med Sci, Dept Neuropsychiat, Fukuoka 812, Japan
关键词
schizophrenia; glutamate receptor; GRIK1; SNP; association study; haplotype analysis;
D O I
10.1097/00041444-200109000-00005
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The glutamatergic dysfunction hypothesis suggests genes involved in glutamatergic transmission as candidates for schizophrenia susceptibility genes. We screened single nucleotide polymorphisms (SNPs) in the entire coding sequence of the GluR5 kainate receptor gene, GRIK1, by polymerase chain reaction-single strand conformation polymorphism and direct sequencing. We identified six SNPs including three known ones, 522A/C (174T, synonymous), 1173C/T (391D, synonymous), and 2705C/T (902L/S), as well as three novel ones, 995C/T (332A/V), 2400C/T (800L, synonymous), and 2585A/G (862R/Q). We genotyped Japanese samples of schizophrenia (n = 193-203) and healthy controls (n = 199-215) for three SNPs those were commonly observed in our samples, 522A/C, 1173C/T, and 2705C/T. We observed no significant associations of the SNPs and their haplotypes with schizophrenia. Therefore, we conclude that GRIK1 does not play a major role in schizophrenia pathogenesis in the Japanese population. Psychiatr Genet 11:139-144 (C) 2001 Lippincott Williams & Wilkins.
引用
收藏
页码:139 / 144
页数:6
相关论文
共 19 条
[1]   Structure of a glutamate-receptor ligand-binding core in complex with kainate [J].
Armstrong, N ;
Sun, Y ;
Chen, GQ ;
Gouaux, E .
NATURE, 1998, 395 (6705) :913-917
[2]   Genomic organization, proposed alternative splicing mechanisms, and RNA editing structure of GRIK1 [J].
Barbon, A ;
Barlati, S .
CYTOGENETICS AND CELL GENETICS, 2000, 88 (3-4) :236-239
[3]  
Cheng HF, 1997, J FOOD DRUG ANAL, V5, P41
[4]  
JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301
[5]   Structure and polymorphisms of the human metabotropic glutamate receptor type 2 gene (GRM2):: analysis of association with schizophrenia [J].
Joo, A ;
Shibata, H ;
Ninomiya, H ;
Kawasaki, H ;
Tashiro, N ;
Fukumaki, Y .
MOLECULAR PSYCHIATRY, 2001, 6 (02) :186-192
[6]   A RAPID NONENZYMATIC METHOD FOR THE PREPARATION OF HMW DNA FROM BLOOD FOR RFLP STUDIES [J].
LAHIRI, DK ;
NURNBERGER, JI .
NUCLEIC ACIDS RESEARCH, 1991, 19 (19) :5444-5444
[7]   STUDY OF A NEW SCHIZOPHRENOMIMETIC DRUG - SERNYL [J].
LUBY, ED ;
COHEN, BD ;
ROSENBAUM, G ;
GOTTLIEB, JS ;
KELLEY, R .
ARCHIVES OF NEUROLOGY AND PSYCHIATRY, 1959, 81 (03) :363-369
[8]   Glutamate receptor expression in schizophrenic brain [J].
Meador-Woodruff, JH ;
Healy, DJ .
BRAIN RESEARCH REVIEWS, 2000, 31 (2-3) :288-294
[9]   Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats [J].
Moghaddam, B ;
Adams, BW .
SCIENCE, 1998, 281 (5381) :1349-1352
[10]  
Moghaddam B, 1997, J NEUROSCI, V17, P2921